公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2012 | Current diagnosis and management of mucopolysaccharidosis VI in the Asia-Pacific region | WUH-LIANG HWU ; Okuyama T.; But W.M.; Estrada S.; Gu X.; Hui J.; Kosuga M.; Lin S.-P.; Ngu L.-H.; Shi H.; Tanaka A.; Thong M.-K.; Wattanasirichaigoon D.; Wasant P.; McGill J. | Molecular Genetics and Metabolism | 7 | 5 | |
2019 | First-in-human phase i study of fisogatinib (BLU-554) validates aberrant FGF19 signaling as a driver event in hepatocellular carcinoma | Kim R.D.; Sarker D.; Meyer T.; Yau T.; Macarulla T.; Park J.-W.; Choo S.P.; Hollebecque A.; Sung M.W.; Lim H.-Y.; Mazzaferro V.; Trojan J.; Zhu A.X.; Yoon J.-H.; Sharma S.; ZHONG-ZHE LIN ; Chan S.L.; Faivre S.; Feun L.G.; Yen C.-J.; Dufour J.-F.; Palmer D.H.; Llovet J.M.; Manoogian M.; Tugnait M.; Stransky N.; Hagel M.; Kohl N.E.; Lengauer C.; Sherwin C.A.; Schmidt-Kittler O.; Hoeflich K.P.; Shi H.; Wolf B.B.; Kang Y.-K. | Cancer Discovery | 154 | 136 | |
2020 | Radium-223 in Asian patients with castration-resistant prostate cancer with symptomatic bone metastases: A single-arm phase 3 study | Zhou T.; Zhou F.; Guo J.; Shi H.; Yao X.; Guo H.; Yuan J.; Tian Y.; Zhang X.; Wang S.; Jiang Y.; Zou Q.; Zhou D.; Li H.; Li F.; Lee J.L.; CHUNG-HSIN CHEN ; Park S.H.; Ng Q.S.; Ma J.; Zheng R.; Ding Q.; Liu X.; Li R.; Krissel H.; Wagner V.J.; Sun Y. | Asia-Pacific Journal of Clinical Oncology | 6 | 5 |